NSCLC Evolution Studies Refine Biomarkers.
The latest analyses from TRACERx, a major effort to understand the genetic landscape of non-small cell lung cancer, are helping researchers uncover new, potentially prognostic biomarkers and pinpoint T-cell receptors that may be useful in the development of adoptive cellular immunotherapies.